All In MedTech

PMA device

IN.PACT AV Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon

Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

8

PMA pathway

Device trials

2

Naming "IN.PACT AV Paclitaxel-Coated"

MAUDE reports

0

Brand "IN.PACT AV Paclitaxel-Coated", since 2015

PubMed studies

0

Mentioning "IN.PACT AV Paclitaxel-Coated"

AI summary across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

Product review deck

A slide deck reviewing IN.PACT AV Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon

About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.

  • Executive summary and key facts
  • Technology
  • Clinical evidence and trials
  • Regulatory history and safety
  • Reimbursement, market and competition
  • Risks, outlook and sources

AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.

FDA decisions

The newest 6 of 8 decisions filed under this name.

3 more FDA decisions with a free account

Older decisions: P190008-S001, P190008

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

Clinical trials

Device studies on ClinicalTrials.gov that name "IN.PACT AV Paclitaxel-Coated", any status and sponsor, newest update first.

Open in Trial Radar
  • IN.PACT™ AV Access IDE StudyPivotal-lookingCompleted

    Medtronic EndovascularPublic (MDT)

    NCT03041467 · 330 participants · Start Apr 25, 2017 · Primary completion Dec 6, 2018

    Device: IN.PACT AV DCB; Standard Balloon Angioplasty · For: Arteriovenous Fistula Stenosis; Arteriovenous Fistula Occlusion; Arteriovenous Fistula and 1 more

    Sites: Birmingham, Alabama; Tempe, Arizona; Sacramento, California · 29 sites in all

  • Shockwave Medical, Inc.Not on our public-company list

    NCT02923193 · 306 participants · Start Feb 22, 2017 · Primary completion May 12, 2020

    Device: Shockwave Lithoplasty® Peripheral Lithoplasty System · For: Peripheral Arterial Disease

    Sites: Little Rock, Arkansas; Palo Alto, California; Aurora, Colorado · 54 sites in all

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "IN.PACT AV Paclitaxel-Coated", and for the whole product code for context.

This brand

0 reports: 0 malfunction, 0 injury, 0 death

Whole product code PRC

543 reports: 107 malfunction, 427 injury, 9 death

Newest reports for this brand

No MAUDE reports name this brand.

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

Published research

The most relevant PubMed records for "IN.PACT AV Paclitaxel-Coated"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

No PubMed record mentions this device by name.

Other devices of this type

Also filed under product code PRC.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.